These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2287841)

  • 1. Some properties of fibroblasts from a patient with debrancher deficiency.
    Furutani A; Yano O; Gotoh S; Higashi K; Hasegawa E; Ohnishi A
    J UOEH; 1990 Dec; 12(4):411-8. PubMed ID: 2287841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debrancher deficiency: neuromuscular disorder in 5 adults.
    DiMauro S; Hartwig GB; Hays A; Eastwood AB; Franco R; Olarte M; Chang M; Roses AD; Fetell M; Schoenfeldt RS; Stern LZ
    Ann Neurol; 1979 May; 5(5):422-36. PubMed ID: 288318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Debranching enzyme in fibroblasts, amniotic fluid cells and chorionic villi: pre- and postnatal diagnosis of glycogenosis type III.
    van Diggelen OP; Janse HC; Smit GP
    Clin Chim Acta; 1985 Jul; 149(2-3):129-34. PubMed ID: 3161667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein.
    Yang BZ; Stewart C; Ding JH; Chen YT
    Neuromuscul Disord; 1991; 1(3):173-6. PubMed ID: 1822791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen debrancher deficiency is reproduced in muscle culture.
    Miranda AF; DiMauro S; Antler A; Stern LZ; Rowland LP
    Ann Neurol; 1981 Mar; 9(3):283-8. PubMed ID: 6452853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible prenatal diagnosis of type III glycogenosis.
    Maire I; Mathieu M
    J Inherit Metab Dis; 1986; 9(1):89-91. PubMed ID: 2941619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amylo-1,6-glucosidase activity in cultured cells: a deficiency in type III glycogenosis with prenatal studies.
    Besley GT; Cohen PT; Faed MJ; Wolstenholme J
    Prenat Diagn; 1983 Jan; 3(1):13-9. PubMed ID: 6221240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.
    Ding JH; de Barsy T; Brown BI; Coleman RA; Chen YT
    J Pediatr; 1990 Jan; 116(1):95-100. PubMed ID: 2295969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease.
    Chen YT; He JK; Ding JH; Brown BI
    Am J Hum Genet; 1987 Dec; 41(6):1002-15. PubMed ID: 2961257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb.
    Okubo M; Horinishi A; Nakamura N; Aoyama Y; Hashimoto M; Endo Y; Murase T
    Hum Genet; 1998 Jan; 102(1):1-5. PubMed ID: 9490286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutation analysis of glycogen debrancher enzyme gene in five Chinese patients with glycogen storage disease type III].
    Zhuang TF; Qiu ZQ; Wei M; Huang SZ
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):85-8. PubMed ID: 15833157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apparent activity in vivo of the lysosomal pathway of glycogen catabolism in cultured human skin fibroblasts from patients with type III glycogen storage disease.
    Brown DH; Waindle LM; Brown BI
    J Biol Chem; 1978 Jul; 253(14):5005-11. PubMed ID: 353046
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
    Oh SH; Park HD; Ki CS; Choe YH; Lee SY
    Clin Chem Lab Med; 2008; 46(9):1245-9. PubMed ID: 18785866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some cases of Type III glycogen storage disease.
    Rosenfield EL; Popova IA; Chibisov IV
    Clin Chim Acta; 1976 Mar; 67(2):123-30. PubMed ID: 1061645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological characteristics of glycogen storage disease III in skeletal muscle.
    Gershen LD; Prayson BE; Prayson RA
    J Clin Neurosci; 2015 Oct; 22(10):1674-5. PubMed ID: 26067541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin biopsy findings in glycogenosis III: clinical, biochemical, and electrophysiological correlations.
    Sancho S; Navarro C; Fernández JM; Domínguez C; Ortega A; Roig M; Cervera C
    Ann Neurol; 1990 May; 27(5):480-6. PubMed ID: 2360788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of a fluorimetric for determining the activity of amylo-1,6-glucosidase in leukocytes for confirming the diagnosis of glycogen storage disease type III].
    Miadi-Messaoud H; Mili A; Ben Khalifa H; Limem K
    Ann Biol Clin (Paris); 2011; 69(1):41-5. PubMed ID: 21463994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis.
    Ugawa Y; Inoue K; Takemura T; Iwamasa T
    Ann Neurol; 1986 Mar; 19(3):294-7. PubMed ID: 3457549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of [14C]glucose into alpha-1,4 bonds of glycogen by leukocytes and fibroblasts of patients with type III glycogen storage disease.
    Gutman A; Barash V; Schramm H; Deckelbaum RJ; Granot E; Aker M; Kohn G
    Pediatr Res; 1985 Jan; 19(1):28-32. PubMed ID: 3918291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological findings in the biopsied muscle of a juvenile type III glycogenosis.
    Hachisuka K; Umezu Y; Nagayoshi M; Hasegawa E; Ohnishi A
    J UOEH; 1990 Dec; 12(4):419-27. PubMed ID: 2287842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.